Arathi Mohan
Clinical Assistant Professor of Internal Medicine
Division of Hematology/Oncology
1500 E. Medical Center Drive, C363 Med Inn
Ann Arbor, Michigan 48109
[email protected]

Available to mentor
Arathi Mohan
Clinical Assistant Professor
  • Qualifications
  • Research Overview
  • Recent Publications
    • Qualifications
    • Fellowship
      University of Michigan–Ann Arbor, Division of Hematology and Oncology, 2022
    • Residency
      Stanford University School of Medicine, Department of Internal Medicine, 2019
    • MD
      Case Western Reserve University, Cleveland, 2016
    • BS
      University of Michigan–Ann Arbor, Division of Hematology/Oncology, 2010
    Research Overview

    • PP2A modulation in advanced solid tumors
    • Cancer genetics

    Recent Publications See All Publications
    • Additional Scholarship
      Data from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.c.6651163.v3
    • Additional Scholarship
      Supplementary Figure S1 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031255.v1
    • Additional Scholarship
      Supplementary Figure S1 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031255
    • Additional Scholarship
      Supplementary Figure S2 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031252
    • Additional Scholarship
      Supplementary Figure S2 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031252.v1
    • Additional Scholarship
      Supplementary Figure S3 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031249.v1
    • Additional Scholarship
      Supplementary Figure S3 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031249
    • Additional Scholarship
      Supplementary Table S1 from Devimistat in combination with gemcitabine and cisplatin in biliary tract cancer: Pre-clinical evaluation and phase 1b multicenter clinical trial (BilT-04)
      Mohan A, Griffith KA, Wuchu F, Zhen DB, Kumar-Sinha C, Crysler O, Hsiehchen D, Enzler T, Dippman D, Gunchick V, Achreja A, Animasahun O, Choppara S, Nenwani M, Chinnaiyan AM, Nagrath D, Zalupski MM, Sahai V. 2024 Sep 16; DOI:10.1158/1078-0432.27031246.v1